Sheba Longevity Center.

What Sheba’s Longevity Center actually is

The first longevity center we are aware of opened inside a major academic teaching hospital, rather than as a commercial clinic with hospital-style branding. Sheba Medical Center, in Ramat Gan, has been ranked repeatedly by Newsweek among the world’s top hospitals, and its Longevity Center — initiated by Prof. Tzipi Strauss and now directed by Dr. Evelyne Bischof — is structurally a hospital department with a longevity-medicine focus, not a private practice.

This matters in three concrete ways.

Triage. When the diagnostic intake surfaces something serious — and at Sheba’s depth, this happens — you are already inside the hospital that will work it up. The cardiology team is down the corridor. The oncology team is down a different corridor. There is no referral chain to navigate, no second clinic to pay, no calendar to manage.

Research integration. Sheba runs an active geroscience research programme, with clinical trials in healthy ageing, cellular interventions and metabolic protocols. Patients have access — under structured informed consent — to interventions that are framed accurately as research rather than as proven longevity science. We credit this kind of explicit labelling.

Conflict structure. As a hospital department with public-healthcare and research-funding components, the financial geometry is materially different from a commercial longevity clinic. The Center does deliver care, but it does not have the same growth-at-all-costs treatment-revenue pressure that drives the commercial sub-sector.

What you get

The diagnostic intake is hospital-grade. Whole-body MRI on the hospital’s imaging suite. Cardiovascular workup with the depth Sheba’s cardiology service provides. Multi-marker bloodwork. Functional and cognitive assessments. Biological-age clocks. Predictive risk modelling using the in-house clinical data science layer.

The Sheba Longevity app, developed with digital health partner YuviTal, is the longitudinal layer — protocol tracking, biomarker re-test scheduling, communication with the clinical team between visits. It is newer than the hospital practice itself, and the longitudinal outcomes data is still accumulating.

Where it falls short

Two honest caveats.

Pricing is not published for the Longevity Center programmes specifically — the medical-tourism model means the headline price varies by programme scope, length, and whether you are an Israeli citizen accessing it through different channels. A typical international intake we have seen quoted sits in the $9,000–18,000 range for a comprehensive programme, but readers should expect to confirm specifics on enquiry.

International travel is the binding constraint. For non-Israeli readers, this is a flight, accommodation in or near Tel Aviv, and at least two to three days on site. The medical-tourism infrastructure around Sheba is well-developed, but the trip is the trip.

The verdict

For the patient who wants longevity medicine delivered inside a hospital — with real triage capacity, real research integration, and a financial structure that isn’t optimised for protocol upselling — Sheba is the cleanest match in our directory. We rank it slightly behind YEARS, Biograph, Early Medical, HLI and Fountain Life on the composite score because the international-travel commitment and the opaque pricing are real frictions for most readers. Where it stands out is the structural fit between the practice and the hospital around it.

A longevity centre inside a hospital is a different proposition to a longevity clinic that opens its own corridor. Both can be excellent. The first triages better.